Moore David Scott — insider trades

Stock trades Moore David Scott reported on SEC Form 4 at CRVS Corvus Pharmaceuticals, Inc..

• Jun 11, 2026: bought 21,700 shares of CRVS Corvus Pharmaceuticals, Inc. ($250K)